← Eichor
Condition: Schizo Affective Type Of Psychosis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Schizo Affective Type Of Psychosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizop
NA · 1 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT07058389Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
NA · 3 location(s) · University of California, San Diego · NCT07098169Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Anal
NA · 1 location(s) · Shanghai Mental Health Center · NCT06904079Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
Phase 1 · 5 location(s) · BioXcel Therapeutics Inc · NCT05025605Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis
NA · 1 location(s) · The Royal Ottawa Mental Health Centre · NCT05973110Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia
NA · 1 location(s) · Mclean Hospital · NCT05343598Synbiotic Compound to Reduce Symptoms of Schizophrenia
Phase 2 · 1 location(s) · Sheppard Pratt Health System · NCT04226898Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Phase N/A · 6 location(s) · Beth Israel Deaconess Medical Center · NCT06740383Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Phase 4 · 1 location(s) · Corporal Michael J. Crescenz VA Medical Center · NCT03495024Visual Perception in Schizophrenia
NA · 1 location(s) · University of Rochester · NCT06911931Enhanced Coordinated Specialty Care for Early Psychosis
NA · 5 location(s) · Mclean Hospital · NCT06071858Effectiveness of Motivation Skills Training (MST)
NA · 2 location(s) · Columbia University · NCT05805397Cerebellar Modulation of Cognition in Psychosis
NA · 2 location(s) · Mclean Hospital · NCT06107764Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
Phase 4 · 7 location(s) · New York State Psychiatric Institute · NCT05208190Exercise and Olanzapine-samidorphan
Phase 4 · 1 location(s) · New York State Psychiatric Institute · NCT06740890Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine
NA · 1 location(s) · Deepak K. Sarpal, M.D. · NCT0600303640 Hz Visual Stimulation as an Intervention in Schizophrenia
NA · 1 location(s) · Technical University of Munich · NCT06907420Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate
Phase 2 · 1 location(s) · National Cheng-Kung University Hospital · NCT06340789FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
NA · 8 location(s) · Stephanie Mehl · NCT07645443A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Sympt
Phase 4 · 22 location(s) · Neurocrine Biosciences · NCT07105111Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
NA · 1 location(s) · Mclean Hospital · NCT06221852The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subje
Phase 4 · 13 location(s) · Dr. Inge Winter · NCT05958875Immune Mechanisms of Antipsychotic Treatment Response
Phase N/A · 1 location(s) · King's College London · NCT06687694Ocrelizumab for Psychosis by Autoimmunity
Phase 1/Phase 2 · 1 location(s) · The Methodist Hospital Research Institute · NCT03971487Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
Phase 4 · 1 location(s) · University of Massachusetts, Worcester · NCT06174116Anticholinergic Deprescription in Schizophrenia
Phase 4 · 1 location(s) · Deepak K. Sarpal, M.D. · NCT06562608Exploring the Feasibility of Transcranial Ultrasound Stimulation in the Treatment of Schizophrenia
NA · 1 location(s) · Far Eastern Memorial Hospital · NCT07621549Acetazolamide for Treatment Resistant Schizophrenia
Phase 1/Phase 2 · 2 location(s) · Vishwajit Nimgaonkar, MD PhD · NCT04887792Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis
NA · 1 location(s) · Charite University, Berlin, Germany · NCT07395206The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receivi
NA · 1 location(s) · DINA KEUMALA SARI · NCT07696000
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.